Cargando…
Antiviral Activity and Increased Host Defense against Influenza Infection Elicited by the Human Cathelicidin LL-37
The extensive world-wide morbidity and mortality caused by influenza A viruses highlights the need for new insights into the host immune response and novel treatment approaches. Cationic Host Defense Peptides (CHDP, also known as antimicrobial peptides), which include cathelicidins and defensins, ar...
Autores principales: | Barlow, Peter G., Svoboda, Pavel, Mackellar, Annie, Nash, Anthony A., York, Ian A., Pohl, Jan, Davidson, Donald J., Donis, Ruben O. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3198734/ https://www.ncbi.nlm.nih.gov/pubmed/22031815 http://dx.doi.org/10.1371/journal.pone.0025333 |
Ejemplares similares
-
The Human Cathelicidin LL-37 Has Antiviral Activity against Respiratory Syncytial Virus
por: Currie, Silke M., et al.
Publicado: (2013) -
Citrullination Alters the Antiviral and Immunomodulatory Activities of the Human Cathelicidin LL-37 During Rhinovirus Infection
por: Casanova, Víctor, et al.
Publicado: (2020) -
Secondary necrosis of apoptotic neutrophils induced by the human cathelicidin LL-37 is not proinflammatory to phagocytosing macrophages
por: Li, Hsin-Ni, et al.
Publicado: (2009) -
Pulmonary defense and the human cathelicidin hCAP-18/LL-37
por: Fahy, R. J., et al.
Publicado: (2005) -
Human cathelicidin, LL-37, inhibits respiratory syncytial virus infection in polarized airway epithelial cells
por: Harcourt, Jennifer L., et al.
Publicado: (2016)